Customize Order

Leave This Empty:

Global Immunocell Therapy Market Research Report 2023

choose chapter to purchase

table of content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunocell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chimeric Antigen Receptor (CAR) T Cell Therapy
1.2.3 Natural Killer (NK) Cell Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Immunocell Therapy Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immunocell Therapy Market Perspective (2018-2029)
2.2 Immunocell Therapy Growth Trends by Region
2.2.1 Immunocell Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immunocell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Immunocell Therapy Forecasted Market Size by Region (2024-2029)
2.3 Immunocell Therapy Market Dynamics
2.3.1 Immunocell Therapy Industry Trends
2.3.2 Immunocell Therapy Market Drivers
2.3.3 Immunocell Therapy Market Challenges
2.3.4 Immunocell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunocell Therapy Players by Revenue
3.1.1 Global Top Immunocell Therapy Players by Revenue (2018-2023)
3.1.2 Global Immunocell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunocell Therapy Revenue
3.4 Global Immunocell Therapy Market Concentration Ratio
3.4.1 Global Immunocell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunocell Therapy Revenue in 2022
3.5 Immunocell Therapy Key Players Head office and Area Served
3.6 Key Players Immunocell Therapy Product Solution and Service
3.7 Date of Enter into Immunocell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunocell Therapy Breakdown Data by Type
4.1 Global Immunocell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Immunocell Therapy Forecasted Market Size by Type (2024-2029)
5 Immunocell Therapy Breakdown Data by Application
5.1 Global Immunocell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Immunocell Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immunocell Therapy Market Size (2018-2029)
6.2 North America Immunocell Therapy Market Size by Country (2018-2023)
6.3 North America Immunocell Therapy Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Immunocell Therapy Market Size (2018-2029)
7.2 Europe Immunocell Therapy Market Size by Country (2018-2023)
7.3 Europe Immunocell Therapy Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunocell Therapy Market Size (2018-2029)
8.2 Asia-Pacific Immunocell Therapy Market Size by Country (2018-2023)
8.3 Asia-Pacific Immunocell Therapy Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Immunocell Therapy Market Size (2018-2029)
9.2 Latin America Immunocell Therapy Market Size by Country (2018-2023)
9.3 Latin America Immunocell Therapy Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunocell Therapy Market Size (2018-2029)
10.2 Middle East & Africa Immunocell Therapy Market Size by Country (2018-2023)
10.3 Middle East & Africa Immunocell Therapy Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Immunocell Therapy Introduction
11.1.4 Gilead Sciences Revenue in Immunocell Therapy Business (2018-2023)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Immunocell Therapy Introduction
11.2.4 Novartis Revenue in Immunocell Therapy Business (2018-2023)
11.2.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details